Melanie Bolch Isbill

Director/Miembro de la Junta en The Michael J. Fox Foundation for Parkinson's Research .

Commercial Services

Consumer Services

Perfil

Melanie Bolch Isbill is currently the Director at The Michael J.
Fox Foundation for Parkinson's Research since 2021.
He completed his undergraduate degree from The Wharton School of the University of Pennsylvania.

Cargos activos de Melanie Bolch Isbill

Empresas	Cargo	Inicio
The Michael J. Fox Foundation for Parkinson's Research The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY.	Director/Miembro de la Junta	11/03/2021

Todos los cargos activos de Melanie Bolch Isbill

Formación de Melanie Bolch Isbill.

The Wharton School of the University of Pennsylvania

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Melanie Bolch Isbill.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
The Michael J. Fox Foundation for Parkinson's Research The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY.	Commercial Services